L & S Advisors Inc Amgen Inc Transaction History

L & S Advisors Inc

$832 Million
Q3 2024

A detailed history of L & S Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, L & S Advisors Inc holds 10,774 shares of AMGN stock, worth $2.85 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

10,774

Previous 20,090 46.37%

Holding current value

$2.85 Million

Previous $6.28 Million 44.7%

% of portfolio

0.42%

Previous 0.81%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $2.88 Million - $3.14 Million	-9,316 Reduced 46.37%	10,774 $3.47 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $2.44 Million - $2.97 Million	9,291 Added 86.04%	20,090 $6.28 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $2.19 Million - $2.64 Million	-8,133 Reduced 42.96%	10,799 $3.07 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $310,419 - $350,190	-1,214 Reduced 6.03%	18,932 $5.45 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $4.4 Million - $5.47 Million	20,146 New	20,146 $5.41 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $1.52 Million - $1.93 Million	-6,635 Reduced 26.26%	18,632 $4.89 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $73,622 - $83,033	328 Added 1.32%	25,267 $5.7 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $2.63 Million - $2.92 Million	11,379 Added 83.92%	24,939 $6.07 Million
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $370,566 - $409,943	1,690 Added 14.24%	13,560 $3.28 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $2.12 Million - $2.43 Million	10,662 Added 882.62%	11,870 $2.67 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $15,920 - $18,652	-75 Reduced 5.85%	1,208 $257,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $56,059 - $62,193	-240 Reduced 15.76%	1,283 $313,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $10,819 - $12,883	50 Added 3.39%	1,523 $350,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $8,916 - $9,916	38 Added 2.65%	1,473 $374,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $5.03 Million - $6.17 Million	-25,408 Reduced 94.65%	1,435 $338,000
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $2.08 Million - $2.76 Million	-11,407 Reduced 29.82%	26,843 $5.44 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $1.38 Million - $1.77 Million	7,270 Added 23.47%	38,250 $9.22 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $4.17 Million - $4.99 Million	23,938 Added 339.93%	30,980 $6 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $17,503 - $20,518	-105 Reduced 1.47%	7,042 $1.3 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $3.7 Million - $4.17 Million	-20,430 Reduced 74.08%	7,147 $1.36 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $703,966 - $821,754	-3,946 Reduced 12.52%	27,577 $5.37 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $5.84 Million - $6.58 Million	31,523 New	31,523 $6.53 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $2.48 Million - $2.78 Million	-14,721 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $2.46 Million - $2.81 Million	14,721	14,721 $2.75 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.

Account